Personalized Medicine Approaches in Parkinson’s Disease: The Genetic Perspective

Article type: Article Commentary

Authors: Gasser, Thomas^*

Affiliations: Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases, Tübingen, Germany

Correspondence: [*] Correspondence to: Thomas Gasser, MD, Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases, Tübingen, Germany. E-mail: thomas.gasser@uni-tuebingen.de.

Abstract: Recent discoveries with respect to the genetic and molecular basis of Parkinson’s disease have led to an increasing recognition of the etiologic heterogeneity of the disorder. As in other complex diseases, it is hoped that this knowledge will allow the identification of novel therapeutic targets that will eventually lead to a more efficient treatment, based on the patient’s individual genetic predispositions.

DOI: 10.3233/JPD-160876

Journal: Journal of Parkinson's Disease, vol. 6, no. 4, pp. 699-701, 2016